Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Net Asset Momentum
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) recorded a net asset momentum of -23.2% as of December 2024, with net assets of CN¥598.18 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Shanxi C&Y Pharmaceutical Group Co Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shanxi C&Y Pharmaceutical Group Co Ltd Net Asset Momentum (2008–2024)
This chart tracks Shanxi C&Y Pharmaceutical Group Co Ltd's year-over-year net asset growth across 17 annual reporting periods from 2008 to 2024. The most recent momentum reading is -23.2%, with net assets of CN¥598.18 Million CNY as of December 2024. Read Shanxi C&Y Pharmaceutical Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2024)
The table below shows the complete annual net asset history for Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥598.18 Million | CN¥1.55 Billion | CN¥949.55 Million | ▼ -23.2% |
| 2023 | CN¥778.43 Million | CN¥1.43 Billion | CN¥654.64 Million | ▲ +6.7% |
| 2022 | CN¥729.68 Million | CN¥1.58 Billion | CN¥854.64 Million | ▼ -2.0% |
| 2021 | CN¥744.58 Million | CN¥1.53 Billion | CN¥782.23 Million | ▼ -14.7% |
| 2020 | CN¥872.61 Million | CN¥1.80 Billion | CN¥927.91 Million | ▼ -6.4% |
| 2019 | CN¥932.60 Million | CN¥1.80 Billion | CN¥869.43 Million | ▲ +0.1% |
| 2018 | CN¥931.24 Million | CN¥1.50 Billion | CN¥564.47 Million | ▼ -4.1% |
| 2017 | CN¥971.17 Million | CN¥1.52 Billion | CN¥547.42 Million | ▲ +1.7% |
| 2016 | CN¥954.85 Million | CN¥1.43 Billion | CN¥477.74 Million | ▲ +9.4% |
| 2015 | CN¥872.50 Million | CN¥1.31 Billion | CN¥435.93 Million | ▲ +6.0% |
| 2014 | CN¥823.16 Million | CN¥1.18 Billion | CN¥358.17 Million | ▲ +7.3% |
| 2013 | CN¥767.16 Million | CN¥1.09 Billion | CN¥323.21 Million | ▲ +17.8% |
| 2012 | CN¥651.17 Million | CN¥827.16 Million | CN¥175.99 Million | ▲ +12.0% |
| 2011 | CN¥581.17 Million | CN¥702.56 Million | CN¥121.39 Million | ▲ +288.5% |
| 2010 | CN¥149.59 Million | CN¥280.84 Million | CN¥131.25 Million | ▲ +27.2% |
| 2009 | CN¥117.60 Million | CN¥259.51 Million | CN¥141.91 Million | ▲ +10.2% |
| 2008 | CN¥106.70 Million | CN¥224.15 Million | CN¥117.45 Million | — |